Nandrolone decanoate is a steroidal raw material also known as 19-nortestosterone 17-decanoate, Deca, and Deca-Durabolin. AAS Raw Pharma supplies light white crystalline Nandrolone decanoate raw powder with a stated assay of 99% minimum for qualified laboratory research, analytical reference work, method development, and legally authorised pharmaceutical manufacturing.
The compound is identified by CAS 360-70-3, molecular formula C28H44O3, and molecular weight 428.65 g/mol. Independent reference sources — PubChem, the FDA substance record, the USP monograph, and European Pharmacopoeia reference-standard listings — report consistent identity data for this substance.
AAS Raw Pharma supports sample, development, and bulk enquiries subject to product availability, customer verification, destination regulations, and a documented lawful end use. Minimum order quantities start at small evaluation quantities, with supply capacity assessed per order.
Important notice: This listing is for a bulk chemical raw material. It is not a finished medicine, sterile injectable preparation, dietary supplement, or consumer product, and it is not intended for direct human or veterinary administration. Nandrolone decanoate is a controlled substance in many jurisdictions. Buyers are responsible for confirming that purchase, possession, importation, handling, storage, processing, and intended use are lawful.
Nandrolone decanoate is the decanoate ester of nandrolone. The ester group distinguishes it from Nandrolone Phenylpropionate, Nandrolone Laurate, Nandrolone Propionate, and unesterified nandrolone base. Each of these is a separate chemical substance with its own CAS number, molecular formula, and molecular weight.
The substance is widely recognised under the names Deca, Deca-Durabolin, and Retabolil. It is one of the most widely referenced nandrolone esters and has appeared in pharmaceutical markets internationally.
AAS Raw Pharma supplies the material strictly as a bulk raw active ingredient for qualified professional customers. The powder has not been formulated, sterilised, or released as a finished pharmaceutical product. Community and supplier pages frequently describe this compound in bodybuilding terms; this listing does not, and restricts itself to what the material is and how it can be documented and supplied.
| Specification | Product details |
|---|---|
| Product name | Nandrolone Decanoate |
| Alternative name | 19-Nortestosterone 17-decanoate |
| Additional synonyms | 19-Nortestosterone decanoate, Retabolil, Deca-Durabolin |
| Common market names | Deca, Deca-Durabolin |
| Chemical description | Estr-4-en-3-one, 17-[(1-oxodecyl)oxy]-, (17-beta)- |
| CAS number | 360-70-3 |
| EINECS number | 206-639-3 |
| UNII | H45187T098 |
| Molecular formula | C28H44O3 |
| Molecular weight | 428.65 g/mol |
| Exact mass | 428.329045 |
| Stated assay | 99% minimum, subject to batch documentation |
| Appearance | Light white crystalline powder |
| Physical form | Crystalline solid |
| Melting point | Approximately 33-37 degrees C |
| Listed grade | Pharmaceutical raw-material grade |
| Packaging | Sealed foil bag or tin |
| Documentation | Batch-specific COA and technical documents where available |
| Minimum order | 1 g evaluation quantity, subject to approval |
| Supply ability | Assessed per order and current production schedule |
| Delivery | Courier, door to door where lawful, 5-7 working days indicative |
| Intended users | Qualified laboratories, institutions, and authorised manufacturers |
| Direct administration | Not permitted; this is not a finished product |
The identity values are independently supported. PubChem records CID 9677 with formula C28H44O3 and molecular weight 428.6 g/mol. The FDA’s validated substance record lists Nandrolone Decanoate under UNII H45187T098 with CAS 360-70-3 and a molecular weight of 428.65. The USP monograph gives the same formula and molecular weight.
Two supplier figures in the supplied draft are imprecise and should be tightened before publication: the delivery window and the monthly supply capacity. A stated 5-7 working-day delivery and “5-10 kg per month” capacity should either be confirmed as current or replaced with “indicative lead time” and “assessed per order.”
The substance is identified by:
ChemSpider records the monoisotopic mass as 428.329045 and the average mass as 428.657. Chemical databases record the MDL number and a melting point of 33-37 degrees C for the substance.
These identifiers should appear consistently in quotations, purchase orders, quality records, package labels, and receiving documentation. Using the full chemical name and CAS number reduces the risk of confusion with other nandrolone esters.
The material appears under a number of names in catalogues, databases, and commercial enquiries:
The FDA record lists the systematic name 17-beta-hydroxyestr-4-en-3-one 17-decanoate alongside the official name Nandrolone Decanoate, and notes the controlled-substance suffix “CIII” on one common-name variant.
The supplied draft repeats “Nandrolone Decanoate” and “Decadurabolin” several times in an alias string that also contains the words “anabolic,” “bodybuilding,” “steroid powder,” and “Deca.” That construction should be replaced with a clean synonym list. Repeating one keyword many times inside an attribute field does not help a page rank and reads as keyword stuffing to both buyers and search systems.
AAS Raw Pharma describes the product as light white crystalline powder. Established manufacturer and pharmacopoeial descriptions characterise Nandrolone Decanoate as a fine, white to creamy-white crystalline powder that is odourless or may have a slight odour, and practically insoluble in water.
Current raw-material catalogues typically describe a white to off-white crystalline powder.
Colour and texture can vary slightly between batches and confirm neither identity nor purity. Visual inspection should be one part of an incoming-material procedure that includes documentation verification and appropriate analytical testing.
The stated assay for this product is 99% minimum, subject to confirmation in the documentation for the supplied batch. An assay figure should always be read together with the method used, the batch tested, the acceptance criteria, and the resulting report.
For reference, the USP monograph for Nandrolone Decanoate specifies a content range of not less than 97.0 percent and not more than 103.0 percent of C28H44O3, calculated on the dried basis. That range applies to material tested against that monograph and cannot be used to substantiate the AAS Raw Pharma batch, which must be documented on its own Certificate of Analysis.
Supplier pages frequently quote an assay of 99% or higher without publishing the supporting method or report. AAS Raw Pharma should publish assay claims only where a corresponding batch record exists.
A Certificate of Analysis, or COA, is a batch-specific quality document summarising the tests performed and results obtained for a defined lot. Depending on the AAS Raw Pharma specification, a COA may include:
The USP monograph for this substance describes identity testing, melting-range determination, an impurity limit where the sum of all impurities is not more than 3.0 percent, and an ultraviolet assay on a dried basis. Those are monograph requirements, not automatic characteristics of any commercially supplied batch.
Customers should verify that the lot number on any AAS Raw Pharma COA matches the number on the packaging, and should retain the documents with their incoming-material and release records.
Quality evaluation of a steroidal raw material can extend well beyond a single assay figure. Depending on the agreed specification and lawful intended application, assessment may cover:
Some supplier pages describe USP grade, GMP manufacturing, or ISO certification. Those claims belong to those suppliers and their products. Do not apply them to an AAS Raw Pharma batch unless AAS Raw Pharma holds current, verifiable evidence.
Customers operating under formal quality systems should apply their own approved supplier, sampling, quarantine, testing, review, and release procedures.
The supplied draft describes this material as an anabolic agent with a differentiation index of 12 and a reference standard or grade that should be stated precisely. The current page does not carry a clearly stated pharmacopoeial standard, so one should be added only if batch documentation supports it.
Describing a material as pharmaceutical grade does not by itself establish that the powder is:
If the product is manufactured against an internal or enterprise specification, describe it that way. Precise wording is more credible — and safer — than a broad quality claim.
AAS Raw Pharma’s supplied information specifies refrigeration preservation, and this matches published guidance. The USP monograph directs that Nandrolone Decanoate be preserved in tight, light-resistant containers and stored in a refrigerator. European Pharmacopoeia reference-standard listings state a storage temperature of -20 degrees C for the neat reference material. Chemical databases commonly list 2-8 degrees C for the substance, and some manufacturers state controlled room temperature for their specific API handling.
Because published storage conditions differ between product formats, the correct condition for the AAS Raw Pharma raw powder must come from its own label, specification, or stability data. General practice:
The substance has a reported melting point of approximately 33-37 degrees C, which means it can soften or clump at warm ambient temperatures. That behaviour should be described accurately and supported by batch documentation if it is to be published as a handling note.
Nandrolone Decanoate should be treated as a hazardous substance in a professional setting. PubChem records primary hazards including acute toxicity, irritant, and health-hazard classifications for the substance. A supplier Safety Data Sheet lists respiratory and skin-irritation precautions, directs that the container be kept tightly closed in a cool, well-ventilated place, and instructs that the material be stored locked up. A second Safety Data Sheet classifies the substance for research and development use only, not for medicinal, household, or other use.
Appropriate handling controls may include:
The powder must not be tasted, swallowed, inhaled, injected, or applied to the body, and must never be administered to a person or animal. It must be kept away from children and unauthorised persons. Personnel should review the applicable Safety Data Sheet before opening or handling the material.
Nandrolone Decanoate is a controlled substance in a number of jurisdictions. The FDA substance record carries the controlled-substance common-name variant “Nandrolone Decanoate CIII,” reflecting its Schedule III classification in the United States. A supplier Safety Data Sheet identifies the same material as “Nandrolone Decanoate USP CIII.” Sigma-Aldrich notes that the European Pharmacopoeia reference standard is regulated under Canadian controlled-drug legislation and is not available from its Canadian operation.
Classification elsewhere differs. Depending on destination and intended use, a purchaser may require:
The buyer should obtain independent legal and regulatory advice where necessary. Publishing this product page does not establish that the substance may be acquired, imported, or used in any particular location.
The supplied draft contains clinical treatment frameworks, personal-use descriptions, and shipping practices that are inappropriate for a raw-material product page. These should be removed or replaced:
| Remove or rewrite | Reason |
|---|---|
| “Used for chronic wasting disease, premature children, malnutrition, osteoporosis and after-operation” | Clinical indication claims for a raw chemical |
| “Promoting the process of tissue formation, reversing the alienation effect” | Therapeutic-effect claims |
| “Effect can support three weeks once injected” | Injection and dosing framing |
| “For elders and postmenopausal osteoporosis, should be intermittent treatment” | Treatment protocol for a bulk material |
| “Once occurred male feature should stop instantly” | Clinical adverse-event management instructions |
| “Pay attention to the symptoms of jaundice… must stop drug” | Clinical monitoring and prescribing guidance |
| “For children… X light view skeletal maturity degree” | Paediatric treatment instructions |
| “Designed for the sole purpose of increasing mass” | Personal-use and performance claim |
| “Leading to a more muscular physique” | Bodybuilding outcome claim |
| “Only pharmaceutical injectables widely available to bodybuilders and economical” | Personal-use market framing |
| “5-alpha reductase enzyme acts to reduce the potency of nandrolone” | Pharmacological potency discussion for a raw material |
| “Well disguised packing,” “100% custom rate,” “Quality Guarantee 100%” | Unsupportable shipping and quality assurances |
| Repeated alias string containing “anabolic, bodybuilding, steroid powder, Deca” | Keyword stuffing in an attribute field |
Removing these passages protects the page from unsubstantiated-claim risk and keeps the listing focused on what it actually is: a documented raw chemical material for lawful professional use.
A crystalline raw material is fundamentally different from a sterile finished medicine. Manufacturing a regulated injectable requires controls that may include approved formulation development, qualified starting materials, validated facilities and processes, sterility assurance, endotoxin control, particulate testing, container-closure qualification, stability studies, finished-product release testing, and regulatory authorisation.
The USP monograph for Nandrolone Decanoate Injection describes a sterile solution of the active substance in sesame oil with a suitable preservative, held to its own content limits and identification tests. That finished-product monograph applies to a manufactured injection, not to bulk powder.
A stated assay of 99% minimum does not demonstrate sterility, freedom from endotoxins, injectable suitability, clinical safety, or regulatory approval. AAS Raw Pharma does not provide compounding, conversion, filtration, injection, or administration instructions.
Subject to applicable law and customer qualification, Nandrolone Decanoate raw material may be relevant to:
A laboratory Safety Data Sheet for this substance describes its relevant identified use as research and development only. That framing fits a bulk raw material listing.
Availability does not authorise any particular use. Each buyer must confirm that its organisation, personnel, facilities, licences, and intended activity comply with the applicable regulatory framework.
Nandrolone Decanoate and Nandrolone Phenylpropionate are related but chemically distinct substances with different ester groups.
| Feature | Nandrolone Decanoate | Nandrolone Phenylpropionate |
|---|---|---|
| Ester group | Decanoate | Phenylpropionate (phenpropionate) |
| CAS number | 360-70-3 | 62-90-8 |
| Molecular formula | C28H44O3 | C27H34O3 |
| Molecular weight | Approximately 428.65 g/mol | Approximately 406.56 g/mol |
| Common market names | Deca, Deca-Durabolin | NPP, Durabolin |
| Same raw material | No | No |
| Interchangeable | No | No |
Both are nandrolone esters, but they are separate products and must be specified precisely on quotations, purchase orders, and receiving documents.
Nandrolone Decanoate is also distinct from unesterified nandrolone.
| Feature | Nandrolone Decanoate | Nandrolone base |
|---|---|---|
| Chemical form | Decanoate ester | Unesterified parent compound |
| CAS number | 360-70-3 | 434-22-0 |
| Molecular formula | C28H44O3 | C18H26O2 |
| Molecular weight | Approximately 428.65 g/mol | Approximately 274.4 g/mol |
Supplier pages occasionally publish an unesterified-nandrolone formula or molecular weight against a Nandrolone Decanoate listing. That is an identity error. Conflicting formula or molecular-weight data should be treated as a red flag, and identity should be verified against authoritative references before ordering.
Packaging should protect the powder from moisture, light, contamination, and physical damage while maintaining clear product and batch identification. Options may include:
Every package should carry the product name, CAS number, batch reference, quantity, and relevant handling information. The final packaging configuration and pack sizes should be confirmed against current stock and the quotation.
Packaging must satisfy applicable carrier, export, import, and destination requirements. AAS Raw Pharma does not offer disguised, mislabeled, or falsely declared shipments, and shipping documents and customs declarations must accurately identify the goods.
Samples may be available to qualified laboratories, institutions, and authorised buyers, subject to inventory, customer verification, destination law, and intended lawful use. Sample availability and any associated charges should be confirmed in writing rather than published as a standing offer.
For a sample or bulk quotation, provide:
Availability, minimum order quantity, pricing, monthly capacity, and lead time should be confirmed in a formal quotation. The supplied draft’s “1 g minimum order” and capacity figures can be published once confirmed as current.
AAS Raw Pharma supports qualified customers seeking documented steroidal raw materials for lawful professional applications.
The listed assay is 99% minimum, subject to the analytical results documented for the supplied batch.
The product is described using its correct chemical name, CAS number, molecular formula, and molecular weight, drawn from authoritative reference data.
Customers may request the available COA, SDS, specification, and supporting technical information for the current batch before purchase.
Direct commercial sourcing can support competitive quotations for approved evaluation and bulk requirements. Final pricing depends on quantity, testing, packaging, stock, and destination.
Small evaluation quantities and larger bulk requirements can be assessed according to stock, customer qualification, and applicable regulations.
Packaging is selected to protect the powder and preserve product and batch identification throughout lawful storage and transport.
The sales team can review logistics options for destinations where exportation, transport, importation, possession, and intended use are lawful.
Support is available for specifications, documentation, quotations, packaging, and shipment enquiries. Any discrepancy should be reported promptly with the relevant order and batch details.
Send AAS Raw Pharma complete and accurate purchasing information:
AAS Raw Pharma may request additional information before accepting an order. Submission of an enquiry does not guarantee availability, customs clearance, or approval.
International delivery may be considered where the shipment is lawful and accepted by an appropriate carrier. Possible providers may include DHL, FedEx, UPS, TNT, EMS, or a specialist freight service, depending on route, quantity, classification, and packaging.
The buyer is responsible for confirming import eligibility, customs classification, controlled-substance rules, pharmaceutical or veterinary licensing, carrier acceptance, duties and taxes, storage obligations, and local possession requirements.
Because Nandrolone Decanoate is controlled in many countries, an import may require documentation and licensing that a non-controlled chemical would not. AAS Raw Pharma does not guarantee customs clearance and does not support deceptive labels, false values, or inaccurate declarations.
This page provides technical and commercial information about a raw chemical material. It does not recommend Nandrolone Decanoate for bodybuilding, muscle growth, joint relief, athletic performance, weight management, hormone therapy, bone health, anaemia, or any personal application.
No dosage, cycle, injection, treatment, or stacking guidance is included. Such information is inappropriate for a bulk raw ingredient and could facilitate unsafe or unlawful administration.
AAS Raw Pharma does not claim that this raw material diagnoses, treats, cures, or prevents any disease. Any legitimate medical use of a finished medicine must be determined by a licensed healthcare professional and governed by the relevant regulator.
Nandrolone decanoate is the decanoate ester of nandrolone, supplied as a bulk crystalline raw material for qualified research, analytical, and legally authorised professional applications.
Deca and Deca-Durabolin are market and brand-associated names for Nandrolone Decanoate. The raw powder offered by AAS Raw Pharma is not a finished branded medicine.
The CAS number is 360-70-3.
The molecular formula is C28H44O3.
The molecular weight is approximately 428.65 g/mol.
The AAS Raw Pharma specification describes a light white crystalline powder. Published descriptions characterise the substance as a fine white to creamy-white crystalline powder that is odourless or nearly odourless.
Published references give a melting point of approximately 33-37 degrees C, which is why the material can soften or clump at warm ambient temperatures.
The stated assay is 99% minimum, subject to the batch’s Certificate of Analysis.
Batch documentation may be available on request. Customers should confirm the exact COA, SDS, and specification supplied with their order.
Sterility must not be assumed. Unless a batch has been produced, tested, and released to a documented sterile specification, treat it as non-sterile raw material.
No. Raw powder is not a sterile injectable preparation and must not be injected or administered.
No. It is not intended for direct ingestion, injection, self-administration, veterinary use, or any personal application.
No. Dosage, treatment, cycle, and injection instructions are inappropriate for a bulk raw chemical.
No. They contain different ester groups and are separate chemical substances with different CAS numbers, formulas, and molecular weights.
No. Nandrolone Decanoate and unesterified nandrolone have different CAS numbers, formulas, and molecular weights.
Keep it tightly closed and protected from light, under the refrigerated condition stated in the batch documentation, in a secure and access-controlled area.
Samples may be available to qualified customers, subject to inventory, intended use, verification, destination law, and commercial terms.
Bulk enquiries can be assessed according to stock, production capacity, documentation, quantity, customer qualification, and destination requirements.
Possible formats include sealed foil bags, tins, protective containers, or approved bulk packaging, depending on quantity and transport needs.
International delivery may be possible where exportation, transport, importation, possession, and intended use are lawful.
No. The buyer is responsible for permits, declarations, duties, taxes, and destination-country requirements.
Provide the quantity, destination, organisation details, intended lawful use, packaging preference, and required documentation. AAS Raw Pharma can then assess the enquiry.
| Specification | Product details |
|---|---|
| Product name | Nandrolone Decanoate |
| Alternative name | 19-Nortestosterone 17-decanoate |
| Additional synonyms | 19-Nortestosterone decanoate, Retabolil, Deca-Durabolin |
| Common market names | Deca, Deca-Durabolin |
| Chemical description | Estr-4-en-3-one, 17-[(1-oxodecyl)oxy]-, (17-beta)- |
| CAS number | 360-70-3 |
| EINECS number | 206-639-3 |
| UNII | H45187T098 |
| Molecular formula | C28H44O3 |
| Molecular weight | 428.65 g/mol |
| Exact mass | 428.329045 |
| Stated assay | 99% minimum, subject to batch documentation |
| Appearance | Light white crystalline powder |
| Physical form | Crystalline solid |
| Melting point | Approximately 33-37 degrees C |
| Listed grade | Pharmaceutical raw-material grade |
| Packaging | Sealed foil bag or tin |
| Documentation | Batch-specific COA and technical documents where available |
| Minimum order | 1 g evaluation quantity, subject to approval |
| Supply ability | Assessed per order and current production schedule |
| Delivery | Courier, door to door where lawful, 5-7 working days indicative |
| Intended users | Qualified laboratories, institutions, and authorised manufacturers |
| Direct administration | Not permitted; this is not a finished product |
